| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/29/2010 | WO2010064012A3 Treatment of autoimmune disease by modulating annexin-i (lipocortin 1 ) |
| 07/29/2010 | WO2010054878A3 Hypoallergenic dermatological composition |
| 07/29/2010 | WO2010054321A3 Methods of treating autoimmune disorders and/or inflammatory disorders |
| 07/29/2010 | WO2010014930A3 Piperidine derivatives as jak3 inhibitors |
| 07/29/2010 | WO2009068482A8 Amino triazoles as pi3k inhibitors |
| 07/29/2010 | US20100190838 Connective Tissue Growth Factor Fragments and Methods and Uses Thereof |
| 07/29/2010 | US20100190830 (3-Amino-1,2,3,4-Tetrahydro-9H-Carbazol-9-yl)-Acetic Acid Derivatives |
| 07/29/2010 | US20100190820 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 07/29/2010 | US20100190813 Spiro [piperidine-4- 4' -thieno [3,2-c] pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis |
| 07/29/2010 | US20100190811 Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors |
| 07/29/2010 | US20100190804 Macrocyclic compounds and their use as kinase inhibitors |
| 07/29/2010 | US20100190799 Phenazine compounds and use thereof in autoimmune and inflammatory diseases |
| 07/29/2010 | US20100190781 Sigma receptor inhibitors |
| 07/29/2010 | US20100190780 Sigma receptor inhibitors |
| 07/29/2010 | US20100190775 Pyrimidodiazepinone derivative |
| 07/29/2010 | US20100190769 Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase |
| 07/29/2010 | US20100190762 Triazolyl phenyl benzenesulfonamides |
| 07/29/2010 | US20100190729 Composition for treating atopic dermatitis comprising hirsutanonol or oregonin as an active ingredient |
| 07/29/2010 | US20100190724 Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection |
| 07/29/2010 | US20100190722 Substance p and thyrotropin releasing hormone for therapeutic applications |
| 07/29/2010 | US20100190717 Use of melanin concentrating hormone and met-enkephalin as therapeutic agents |
| 07/29/2010 | US20100190716 Use of a platelet fibrinogen receptor hexapeptide antagonist and alpha-endorphin as therapeutic agents |
| 07/29/2010 | US20100190713 Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agent |
| 07/29/2010 | US20100190712 Use of peptide yy, alone or in combination with glucagon-like peptide, for use in medicine |
| 07/29/2010 | US20100190711 Big gastrin i as a therapeutic agent |
| 07/29/2010 | US20100190710 Il-23 receptor antagonists and uses thereof |
| 07/29/2010 | US20100190696 Treatment of t-cell mediated diseases |
| 07/29/2010 | US20100189830 Sweet Gum Fruit Extract as a Therapeutic Agent |
| 07/29/2010 | US20100189819 Neuro-degenerative inhibitor, neuro-endocrine modulator, and neuro-cerebral metabolism enhancer |
| 07/29/2010 | US20100189773 5-cyano-4- (pyrrolo [2,3] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 07/29/2010 | US20100189748 Inactivated staphylococcal whole-cell vaccine |
| 07/29/2010 | US20100189746 Adaptation of pitman moore strain of rabies virus to primary chick embryo fibroblast cell cultures |
| 07/29/2010 | US20100189739 Immunogenic compositions comprising dal/dat double mutant, auxotrophic attenuated strains of Listeria and their methods of use |
| 07/29/2010 | US20100189729 Rna-coded antibody |
| 07/29/2010 | US20100189720 Novel card proteins involved in cell death regulation |
| 07/29/2010 | US20100189718 Molecules with extended half-lives, compositions and uses thereof |
| 07/29/2010 | US20100189717 Plant Recombinant Human CTLA4IG and a Method for Producing the Same |
| 07/29/2010 | US20100189696 Lithium stimulation of cord blood stem cell proliferation and growth factor production |
| 07/29/2010 | US20100189692 Probiotics for use in reducing eosinophilia and respiratory allergies |
| 07/29/2010 | US20100189690 Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high throughput screening |
| 07/29/2010 | US20100189686 Albumin Fusion Proteins |
| 07/29/2010 | US20100189682 Biologically active proteins having increased In Vivo and/or In Vitro stability |
| 07/29/2010 | US20100189644 Arginase inhibitors and methods of use |
| 07/29/2010 | DE10392697B4 Extrakt von Peptid-verknüpften Glucanen und Peptid-verknüpfte Clucane mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor und deren Reinigungsverfahren und Verwendungen Extract of peptide-linked glucans and peptide-linked Clucane with detectable oral absorbability from Coriolus versicolor and their cleaning methods and uses |
| 07/29/2010 | CA2750581A1 Pta089 protein |
| 07/29/2010 | CA2750510A1 Treatment of neurotrophic factor mediated disorders |
| 07/29/2010 | CA2750444A1 Anti-cd 160 monoclonal antibodies and uses thereof |
| 07/29/2010 | CA2750098A1 Compositions and methods for induction of antigen-specific tolerance |
| 07/29/2010 | CA2749120A1 Improved vaccines for human papilloma virus and methods for using the same |
| 07/29/2010 | CA2747801A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity |
| 07/28/2010 | EP2210903A1 Anti-CD160 monoclonal antibodies and uses thereof |
| 07/28/2010 | EP2210902A1 Recombinant monovalent antibodies |
| 07/28/2010 | EP2210890A1 Oxadiazole derivatives as S1P1 receptor agonists |
| 07/28/2010 | EP2210872A1 New crystalline form III of agometalin, the process for its preparation and pharmaceutical compositions containing it |
| 07/28/2010 | EP2209768A1 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 07/28/2010 | EP2209481A1 Use of microvesicles (mvs) for preparing a medicament having adjuvant activity on endothelial cell transplantation, particularly in the treatment of diabetes by pancreatic islet transplantation, and related method |
| 07/28/2010 | EP1776387B1 Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2 |
| 07/28/2010 | EP1458392B9 Acridones as inhibitors of impdh enzyme |
| 07/28/2010 | EP1250135B1 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 07/28/2010 | CN1984887B Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same |
| 07/28/2010 | CN1974596B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 07/28/2010 | CN1767819B Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol |
| 07/28/2010 | CN1651457B Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens |
| 07/28/2010 | CN101790384A The use of monomycolyl glycerol (mmg) as an adjuvant |
| 07/28/2010 | CN101787015A Chiral tricyclic compounds with anti-histamine activity, preparation method and application |
| 07/28/2010 | CN101787000A M-stage kinesin inhibitor |
| 07/28/2010 | CN101786993A 1, 2, 3-triazole compound and application thereof in preparing indoleamine 2, 3-dioxygenase inhibitor |
| 07/28/2010 | CN101785836A Traditional Chinese medicine ointment, preparation method and application thereof for skin disease treatment |
| 07/28/2010 | CN101785832A Traditional Chinese medicine preparation and preparation method thereof for skin disease treatment |
| 07/28/2010 | CN101785810A Traditional Chinese medicine preparation for anaphylactoid purpura treatment |
| 07/28/2010 | CN101785793A Application of antradiacomphora extract capsule for protecting liver and promoting body immune regulation function |
| 07/28/2010 | CN101785791A Traditional Chinese medicine for infantile eczema treatment |
| 07/28/2010 | CN101785512A Health protection tea not only having nutrition and health protection roles, but also capable of preventing diseases and assisting for treating diseases |
| 07/28/2010 | CN101283985B Enteric oral vaccine for fishing gear and preparation method thereof |
| 07/28/2010 | CN101265302B Panax japonicus polysaccharides, preparation method and use thereof |
| 07/28/2010 | CN101245112B Polyoses extracted from pistacia chinensis meal and extracting method thereof |
| 07/28/2010 | CN101147581B White Chinese sorghum nutritive powder and preparation method thereof |
| 07/28/2010 | CN101124948B Traditional Chinese medicinal composition for raising southern American white prawn |
| 07/27/2010 | US7763752 such as 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentane-1-ol, used for treating autoimmune diseases, rheumatoid arthritis, psoriasis, dermatitis, asthma, hay fever or rejection of organ or bone morrow transplantation; side effect reduction |
| 07/27/2010 | US7763729 Bicyclic heteroaromatic derivatives |
| 07/27/2010 | US7763718 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 07/27/2010 | US7763586 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 07/27/2010 | US7763290 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 07/27/2010 | US7763252 Methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; using reovirus for treatment of cellular proliferative disorders, particularly wherein proliferating cells exhibit constitutive MAPK phosphorylation in mammals; antitumor agents |
| 07/27/2010 | US7763243 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient. |
| 07/27/2010 | CA2436659C Cannabinoid receptor ligands |
| 07/27/2010 | CA2384717C Topical treatment for prevention of ocular infections |
| 07/27/2010 | CA2332829C Vaccine delivery system |
| 07/27/2010 | CA2223300C Expression of lipoproteins |
| 07/22/2010 | WO2010083277A2 Methods for improving hepatic and immune function in an animal |
| 07/22/2010 | WO2010083253A2 Cd47 related compositions and methods for treating immunological diseases and disorders |
| 07/22/2010 | WO2010083218A1 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids |
| 07/22/2010 | WO2010083203A2 Non-embryonic stem cells and uses thereof |
| 07/22/2010 | WO2010082906A1 Use of nerium oleander for diseases manifested with type ii diabetes, obesity, high cholesterol and triglyceride |
| 07/22/2010 | WO2010082798A2 Composition containing extracts of fuscoporia obliqua, ganoderma lucidum and phellinus linteus for promoting the proliferation of hematopoietic stem cells |
| 07/22/2010 | WO2010082136A1 Recombinant monovalent antibodies |
| 07/22/2010 | WO2010081692A1 Oxadiazole derivatives as slpl receptor agonists |
| 07/22/2010 | WO2010081257A1 Composition comprising bacillus calmette guerin polysaccharides and bacillus calmette guerin nucleic acids and use of preparing medicament thereof |
| 07/22/2010 | WO2010048731A8 Aminoacyl trna-synthetase inhibitors as broad-spectrum immunosuppressive agents |
| 07/22/2010 | WO2010039924A3 Th1 vaccination priming for active immunotheraphy |